Navegar

Colección

Datos Estadísticas

Lista de

Alzheimer disease
72
"Executive functioning in cognitively normal middle-aged offspring of late-onset Alzheimer's disease patients" (2019) Abulafia, C.;Fiorentini, L.;Loewenstein, D.A. (...)Guinjoan, S.M. Journal of Psychiatric Research. 112:23-29
"Proteasome stress leads to APP axonal transport defects by promoting its amyloidogenic processing in lysosomes" (2018) Otero, M.G.;Bessone, I.F.;Hallberg, A.E. (...)Falzone, T.L. Journal of Cell Science. 131(11)
"Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: Associations and a hypothesis " (2014) Domínguez, R.O.;Pagano, M.A.;Marschoff, E.R. (...)Serra, J.A. Neurologia. 29(9):567-572
"Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: Associations and a hypothesis " (2014) Domínguez, R.O.;Pagano, M.A.;Marschoff, E.R. (...)Serra, J.A. Neurologia. 29(9):567-572
"Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: Associations and a hypothesis " (2014) Domínguez, R.O.;Pagano, M.A.;Marschoff, E.R. (...)Serra, J.A. Neurologia. 29(9):567-572
"Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52" (2014) Erlejman, A.G.;Lagadari, M.;Harris, D.C. (...)Galigniana, M.D. Current Protein and Peptide Science. 15(3):205-215
"Astroglial mGlu3 receptors promote alpha-secretase-mediated amyloid precursor protein cleavage" (2014) Durand, D.;Carniglia, L.;Beauquis, J. (...)Lasaga, M. Neuropharmacology. 79:180-189
"Hippocampal and cognitive alterations precede amyloid deposition in a mouse model of al- zheimer’s disease " (2014) Beauquis, J.;Vinuesa, Á.;Pomilio, C. (...)Saravia, F. Medicina (Argentina). 74(4):282-286
"Hippocampal and cognitive alterations precede amyloid deposition in a mouse model of al- zheimer’s disease " (2014) Beauquis, J.;Vinuesa, Á.;Pomilio, C. (...)Saravia, F. Medicina (Argentina). 74(4):282-286
"Hippocampal and cognitive alterations precede amyloid deposition in a mouse model of al- zheimer’s disease " (2014) Beauquis, J.;Vinuesa, Á.;Pomilio, C. (...)Saravia, F. Medicina (Argentina). 74(4):282-286
"Hsp90-binding immunophilins as a potential new platform for drug treatment" (2013) Erlejman, A.G.; Lagadari, M.; Galigniana, M.D. Future Medicinal Chemistry. 5(5):591-607
"Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease" (2013) Beauquis, J.;Pavía, P.;Pomilio, C. (...)Saravia, F. Experimental Neurology. 239(1):28-37
"Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease" (2013) Beauquis, J.;Pavía, P.;Pomilio, C. (...)Saravia, F. Experimental Neurology. 239(1):28-37
"Effect of trehalose on the interaction of Alzheimer's Aβ-peptide and anionic lipid monolayers" (2011) Izmitli, A.;Schebor, C.;McGovern, M.P. (...)De Pablo, J.J. Biochimica et Biophysica Acta - Biomembranes. 1808(1):26-33
"Effect of trehalose on the interaction of Alzheimer's Aβ-peptide and anionic lipid monolayers" (2011) Izmitli, A.;Schebor, C.;McGovern, M.P. (...)De Pablo, J.J. Biochimica et Biophysica Acta - Biomembranes. 1808(1):26-33
"Neuroprotective actions of estradiol revisited" (2011) Azcoitia, I.; Arevalo, M.-A.; De Nicola, A.F.; Garcia-Segura, L.M. Trends in Endocrinology and Metabolism. 22(12):467-473
"FKBP51 and FKBP52 in signaling and disease" (2011) Storer, C.L.;Dickey, C.A.;Galigniana, M.D. (...)Cox, M.B. Trends in Endocrinology and Metabolism. 22(12):481-490
"FKBP51 and FKBP52 in signaling and disease" (2011) Storer, C.L.;Dickey, C.A.;Galigniana, M.D. (...)Cox, M.B. Trends in Endocrinology and Metabolism. 22(12):481-490
"NeuroImmunoModulation: Preface" (2010) Pérez Leirós, C.; Arzt, E.; Saravia, F.; Rettori, V. NeuroImmunoModulation. 17(3):137-138
"Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-alzheimer agents" (2010) Galdeano, C.;Viayna, E.;Arroyo, P. (...)Luque, F.J. Current Pharmaceutical Design. 16(25):2818-2836
"Steroid protection in aging and age-associated diseases" (2009) De Nicola, A.F.;Pietranera, L.;Beauquis, J. (...)Saravia, F.E. Experimental Gerontology. 44(1-2):34-40
"Insulin, glucose and glycated hemoglobin in Alzheimer's and vascular dementia with and without superimposed Type II diabetes mellitus condition" (2008) Domínguez, R.O.;Marschoff, E.R.;Guareschi, E.M. (...)Lovecchio, S. Journal of Neural Transmission. 115(1):77-84
"Insulin, glucose and glycated hemoglobin in Alzheimer's and vascular dementia with and without superimposed Type II diabetes mellitus condition" (2008) Domínguez, R.O.;Marschoff, E.R.;Guareschi, E.M. (...)Lovecchio, S. Journal of Neural Transmission. 115(1):77-84
"The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid β peptide: Implications for Alzheimer disease pathogenesis" (2008) Llovera, R.E.;De Tullio, M.;Alonso, L.G. (...)Castaño, E.M. Journal of Biological Chemistry. 283(25):17039-17048
"The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid β peptide: Implications for Alzheimer disease pathogenesis" (2008) Llovera, R.E.;De Tullio, M.;Alonso, L.G. (...)Castaño, E.M. Journal of Biological Chemistry. 283(25):17039-17048
"Inhibition of the α9α10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-d-aspartate receptors" (2007) Plazas, P.V.;Savino, J.;Kracun, S. (...)Elgoyhen, A.B. European Journal of Pharmacology. 566(1-3):11-19
"Homocysteine, vitamin B 12 and folate in Alzheimer's and vascular dementias: The paradoxical effect of the superimposed type II diabetes mellitus condition" (2005) Domínguez, R.O.;Marschoff, E.R.;Guareschi, E.M. (...)Serra, J.A. Clinica Chimica Acta. 359(1-2):163-170
"Homocysteine, vitamin B 12 and folate in Alzheimer's and vascular dementias: The paradoxical effect of the superimposed type II diabetes mellitus condition" (2005) Domínguez, R.O.;Marschoff, E.R.;Guareschi, E.M. (...)Serra, J.A. Clinica Chimica Acta. 359(1-2):163-170
"Oxidative stress in Alzheimer's and vascular dementias: Masking of the antioxidant profiles by a concomitant Type II diabetes mellitus condition" (2004) Serra, J.A.;Marschoff, E.R.;Domínguez, R.O. (...)Lovecchio, S. Journal of the Neurological Sciences. 218(1-2):17-24
"Insulin-degrading enzyme in brain microvessels: Proteolysis of amyloid β vasculotropic variants and reduced activity in cerebral amyloid angiopathy" (2004) Morelli, L.;Llovera, R.E.;Mathov, I. (...)Castaño, E.M. Journal of Biological Chemistry. 279(53):56004-56013
"Generation of amyloid β protein from a presenilin-1 and βAPP complex" (2002) Shizuka-Ikeda, M.;Matsubara, E.;Ikeda, M. (...)St. George-Hyslop, P. Biochemical and Biophysical Research Communications. 292(2):571-578
"The degradation of amyloid β as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses" (2002) Morelli, L.; Llovera, R.; Ibendahl, S.; Castaño, E.M. Neurochemical Research. 27(11):1387-1399
"The degradation of amyloid β as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses" (2002) Morelli, L.; Llovera, R.; Ibendahl, S.; Castaño, E.M. Neurochemical Research. 27(11):1387-1399
"The degradation of amyloid β as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses" (2002) Morelli, L.; Llovera, R.; Ibendahl, S.; Castaño, E.M. Neurochemical Research. 27(11):1387-1399
"The Alzheimer-related gene presenilin-1 facilitates sonic hedgehog expression in Xenopus primary neurogenesis" (2001) Paganelli, A.R.;Ocaña, O.;Prat, M.I. (...)Carrasco, A.E. Mechanisms of Development. 107(1-2):119-131
"Parkinson's disease is associated with oxidative stress: Comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients" (2001) Serra, J.A.;Domínguez, R.O.;De Lustig, E.S. (...)Marschoff, E.R. Journal of Neural Transmission. 108(10):1135-1148
"Parkinson's disease is associated with oxidative stress: Comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients" (2001) Serra, J.A.;Domínguez, R.O.;De Lustig, E.S. (...)Marschoff, E.R. Journal of Neural Transmission. 108(10):1135-1148
"Comparison of the determination of superoxide dismutase and antioxidant capacity in neurological patients using two different procedures" (2000) Serra, J.A.;Marschoff, E.R.;Domínguez, R.O. (...)Guareschi, E.M. Clinica Chimica Acta. 301(1-2):87-102
"Comparison of the determination of superoxide dismutase and antioxidant capacity in neurological patients using two different procedures" (2000) Serra, J.A.;Marschoff, E.R.;Domínguez, R.O. (...)Guareschi, E.M. Clinica Chimica Acta. 301(1-2):87-102
"Impairments of social cognition and decision making in Alzheimer's disease" (2000) Torralva, T.;Dorrego, F.;Sabe, L. (...)Starkstein, S.E. International Psychogeriatrics. 12(3):359-368
"Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia" (1999) Kuzis, G.;Sabe, L.;Tiberti, C. (...)Starkstein, S.E. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 12(4):265-269
"Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia" (1999) Kuzis, G.;Sabe, L.;Tiberti, C. (...)Starkstein, S.E. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 12(4):265-269
"Remote memory in Alzheimer's disease" (1999) Dorrego, M.F.;Sabe, L.;Cuerva, A.G. (...)Starkstein, S.E. Journal of Neuropsychiatry and Clinical Neurosciences. 11(4):490-497
"Prevalence and correlates of the catastrophic reaction in Alzheimer's disease" (1998) Tiberti, C.;Sabe, L.;Kuzis, G. (...)Starkstein, S.E. Neurology. 50(2):546-548
"Anosognosia and procedural learning in Alzheimer's disease" (1997) Starkstein, S.E.;Sabe, L.;Cuerva, A.G. (...)Leiguarda, R. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 10(2):96-101
"Anosognosia and procedural learning in Alzheimer's disease" (1997) Starkstein, S.E.;Sabe, L.;Cuerva, A.G. (...)Leiguarda, R. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 10(2):96-101
"Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease" (1997) Starkstein, S.E.;Sabe, L.;Vázquez, S. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 63(1):66-73
"A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease" (1996) Petracca, G.;Tesón, A.;Chemerinski, E. (...)Starkstein, S.E. Journal of Neuropsychiatry and Clinical Neurosciences. 8(3):270-275
"Two domains of anosognosia in Alzheimer's disease" (1996) Starkstein, S.E.;Sabe, L.;Chemerinski, E. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 61(5):485-490
"Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia" (1996) Starkstem, S.E.;Sabe, L.;Petracca, G. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 61(4):381-387
"The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls" (1996) Famulari, A.L.;Marschoff, E.R.;Llesuy, S.F. (...)De Lustig, E.S. Journal of the Neurological Sciences. 141(1-2):69-78
"Quantified electroencephalographic correlates of neuropsychological deficits in Alzheimer's disease" (1995) Pozzi, D.;Petracchi, M.;Sabe, L. (...)Starkstein, S. Journal of Neuropsychiatry and Clinical Neurosciences. 7(1):61-67
"Quantified electroencephalographic correlates of neuropsychological deficits in Alzheimer's disease" (1995) Pozzi, D.;Petracchi, M.;Sabe, L. (...)Starkstein, S. Journal of Neuropsychiatry and Clinical Neurosciences. 7(1):61-67
"Prevalence and clinical correlates of pathological affective display in Alzheimer's disease" (1995) Starkstein, S.E.;Migliorelli, R.;Teson, A. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 59(1):55-60
"Anosognosia in Alzheimer's disease: A study of associated factors" (1995) Migliorelli, R.;Teson, A.;Sabe, L. (...)Starkstein, S.E. Journal of Neuropsychiatry and Clinical Neurosciences. 7(3):338-344
"A SPECT study of Parkinsonism in Alzheimer's disease" (1995) Starkstein, S.E.;Vazquez, S.;Merello, M. (...)Leiguarda, R. Journal of Neuropsychiatry and Clinical Neurosciences. 7(3):308-313
"Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease" (1995) Migliorelli, R.;Teson, A.;Sabe, L. (...)Starkstein, S.E. American Journal of Psychiatry. 152(1):37-44
"Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease" (1995) Migliorelli, R.;Teson, A.;Sabe, L. (...)Starkstein, S.E. American Journal of Psychiatry. 152(1):37-44
"Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives" (1994) Serra, J.A.;Famulari, A.L.;Kohan, S. (...)de Lustig, E.S. Journal of the Neurological Sciences. 122(2):179-188
"Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives" (1994) Serra, J.A.;Famulari, A.L.;Kohan, S. (...)de Lustig, E.S. Journal of the Neurological Sciences. 122(2):179-188